«El Confidencial»: Ideeea Therapeutics announces AGAcell®: An allogeneic cell therapy program in preclinical development for alopecia.

Ideeea Therapeutics announces AGAcell®: an allogeneic cell therapy program in preclinical development for alopecia. Ideeea Therapeutics closes €2.3 million seed round to advance the development of advanced therapy medicinal products with an open science and high clinical impact approach. AGAcell® is a preclinical research program that explores the use of allogeneic mesenchymal stem cells for […]

Ideeea TX on «Expansión»: Ideeea TX secures €2.3 million in funding to address alopecia through stem cell-based therapy.

Biotech firm Ideeea TX raises €2.3 million to combat alopecia using stem cell therapy The biotech company Ideeea Therapeutics has closed a €2.3 million seed funding round, supported by private investors and the Centre for the Development of Industrial Technology and Innovation (CDTI), within the framework of the Perte (Strategic Projects for Economic Recovery and […]

AGAcell® on «La Sexta»: Ideeea Therapeutics’ Bet on Androgenetic Alopecia

Don’t miss the report aired by La Sexta on AGAcell®, the cell therapy research program from Ideeea Tx, led by Principal Investigator Dr. Eduardo López Bran, in collaboration with Hospital Clínico San Carlos, focused on the treatment of androgenetic alopecia. In the report, Dr. López Bran outlines the progress made in this promising line of research, based […]